Navigation Links
Genomma Lab, New Participant in Market-Maker Program
Date:1/12/2009

MEXICO CITY, Jan. 12 /PRNewswire-FirstCall/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB) ("Genomma Lab" or "the Company") announced that on January 9, 2009, the Company signed an agreement with IXE Casa de Bolsa, S.A. de C.V. to act as the market maker for the Company's outstanding shares, thus becoming another company to participate in the market maker program. The contract will become valid upon approval of the Mexican Stock Exchange (Bolsa Mexicana de Valores) and will be in effect for a minimum period of 12 months from the date of the agreement.

Less than 6 months since becoming a public company, Genomma Lab seeks to leverage the benefits of the modernizing Mexican markets via the market-maker program. The Company expects that its incorporation into this program will allow for increased share liquidity.

With its incorporation into the market-maker program and together with the Share Repurchase program approved by the Board of Directors, Genomma Lab reaffirms its commitment to provide higher liquidity for its shares.

Company Description

Genomma Lab Internacional, S.A.B. de C.V. is a leading over-the-counter pharmaceuticals and personal care products company in Mexico with international presence. Genomma develops, sells and markets a broad range of premium branded products, many of which are leaders in the categories in which they compete in terms of sales and market share.

Genomma Lab performed its Initial Public Offering in June 2008, through a combined offering (mainly primary) and is listed on the Mexican Stock Exchange under the ticker symbol "LAB.B" (Bloomberg: labb.mx).

    Web Site: www.genommalab.com

    Investor Relations Contact:
    Tel: +52 (55) 5081 0000 Ext. 4250
    E-mail: inversion@genommalab.com

    In New York: i-advize Corporate Communications, Inc.
    Tel: (212) 406-3691/95
    E-mail: genomma@i-advize.com

'/>"/>
SOURCE Genomma Lab Internacional, S.A.B. de C.V.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Genomma Lab Announces Initiation of Stock Repurchase Fund
2. Genomma Lab Announces the Successful Launch of the Ma Evans Brand
3. Genomma Lab Announces 2009 Earnings Guidance
4. Genomma Lab Internacional Acquires UNIGASTROZOL
5. Webcast Alert: Genomma Lab Internacional, S.A.B. de C.V. announces Second Quarter 2008 Results Conference Call
6. Genomma Lab Prices Initial Public Offering and Begins Trading on Mexican Stock Exchange
7. Exercising Power to Lead Healthier Lives - 740,000 Participants Cast Votes for Challenger of Year
8. Newport Introduces More Resources for Spanish Speaking Plan Participants
9. Retired Heart Surgeon Dr. Dwight Lundell Celebrates 65th Birthday as an Ironman Participant
10. 25,000 AIDS Walk San Francisco Participants; 25,000 Reasons Why
11. Fight Against Breast Cancer Receives Big Boost During Susan G. Komen Detroit Race for the Cure(R) With 344 Participants From Binsons, Northwood
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Dr. Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile ... orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can ...
(Date:6/24/2016)... ... 24, 2016 , ... The Haute Beauty Network, affiliated with ... as a prominent plastic surgeon and the network’s newest partner. , Dr. ... handsome men, look naturally attractive. Plastic surgery should be invisible.” He stands by ...
(Date:6/24/2016)... MD (PRWEB) , ... June 24, 2016 , ... ... protocols for human induced pluripotent stem (iPS) cells and other difficult to transfect ... G9™ Cloning Medium. The PluriQ™ G9™ Gene Editing System is a ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... ANGELES , June 23, 2016 ... CAPR ), a biotechnology company focused ... therapeutics, today announced that patient enrollment in its ... in Duchenne) has exceeded 50% of its 24-patient ... enrollment in the third quarter of 2016, and ...
(Date:6/23/2016)... and INDIANAPOLIS , June ... receiving a Lilly Diabetes Tomorrow,s Leaders Scholarship is any ... scholarship winners, announced today online at www.diabetesscholars.org ... type 1 diabetes stand in the way of academic ... supported the Foundation,s scholarship program since 2012, and continues ...
(Date:6/23/2016)... , June 23, 2016 The vast majority ... outpatient dialysis facility.  Treatments are usually 3 times a ... per visit, including travel time, equipment preparation and wait ... but especially grueling for patients who are elderly and ... skilled nursing and rehabilitation centers for some duration of ...
Breaking Medicine Technology: